Ken Griffin Neurosense Therapeutics LTD Wt Transaction History

Citadel Advisors LLC

  • $509 Billion
  • Q1 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Neurosense Therapeutics LTD Wt stock. As of the latest transaction made, Citadel Advisors LLC holds 48,138 shares of NRSNW stock, worth $8,664. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,138
Holding current value
$8,664
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.08 - $0.5 $3,851 - $24,069
48,138 New
48,138 $20,000
Q3 2023

Nov 14, 2023
SELL
$0.11 - $0.28 $2,898 - $7,376
-26,346 Reduced 69.45%
11,588 $1,000
Q2 2023

Aug 14, 2023
BUY
$0.2 - $0.46 $1,064 - $2,448
5,323 Added 16.32%
37,934 $9,000
Q1 2023

May 15, 2023
BUY
$0.19 - $0.52 $6,196 - $16,957
32,611 New
32,611 $12,000

Others Institutions Holding NRSNW

# of Institutions
6
Shares Held
395K
Call Options Held
0
Put Options Held
0
View Full List

About NEUROSENSE THERAPEUTICS LTD WT

NRSNW Quotes by TradingView
  • Ticker NRSNW
More about NRSNW
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email